Speakers

Stacey Allaster

Chief Executive of Professional Tennis

United States Tennis Association
- Leveraging The Power of Tennis to Empower Resilience
  Monday, March 11, 2024 | 8:30—9:30 AM
  
  - Sinatra Ballroom Salons 7
Stacey Allaster

Chief Executive of Professional Tennis

United States Tennis Association
- Leveraging The Power of Tennis to Empower Resilience
  Monday, March 11, 2024 | 8:30—9:30 AM
  
  - Sinatra Ballroom Salons 7
Stacey Allaster is an internationally renowned sports and entertainment leader, champion of equality, and trailblazer in the sport of tennis.

Currently, Stacey is the United States Tennis Association’s Chief Executive, Professional Tennis & US Open Tournament Director responsible for setting the strategic vision and growth strategy for the US Open and for the USTA’s professional tennis division. With her appointment to the role of Tournament Director in June 2020, Stacey became the first-ever female tournament director in the organization’s 140-year history.

Previously, Stacey was the Tournament Director of the Canadian Open and the VP of Sales & Marketing. In 2006, she joined the Women’s Tennis Association for three years where she served as President and was later promoted to Chairman and CEO. During her tenure, Stacey grew player prize money by 100 percent, and oversaw the global expansion of women’s professional tennis, including a robust Asia-Pacific growth strategy. Throughout her career, Stacey has been a fierce advocate for equality in women’s sports, playing a lead role in in securing equal prize money for women at Wimbledon and Roland Garros and all major WTA events.

In 2022, Stacey was awarded the Order of Canada in the companion category for her work in gender equality, one of the highest civilian honors in her native country. Additionally, she has been named by Forbes as one of the most powerful women in sport and a 50 over 50 Visionary and most recently the Billie Jean King Leadership award. Stacey is currently a board member of Blue Grace Logistics, the Canadian Olympic Committee, the Women’s Sports Network and numerous advisory boards including the University of South Florida’s College of Business.
Chris J. Anderson

Director, Quality Management

Cardinal Health, Inc.
- C3: The Future of Cold Chain Distribution
- F3: Update and Recent Cold Chain Challenges for Wholesale Distributors
Chris J. Anderson

Director, Quality Management

Cardinal Health, Inc.
- C3: The Future of Cold Chain Distribution
- F3: Update and Recent Cold Chain Challenges for Wholesale Distributors
Chris has been with Cardinal Health since 1987 in Quality and Regulatory Affairs, at both the field and corporate levels, responsible for wholesale drug distribution compliance. Over the past ten years, he has built a quality system supporting the Pharmaceutical Distribution business.

Chris led the development of the current innovative and sustainable cold chain packaging process for Cardinal Health that has been recognized through the industry through various awards, speaking invitations and publications.

In his quality role, Chris has regulatory responsibility for the quality systems that support compliance, temperature management and DSCSA regulatory support.

Chris was a member of the United States Pharmacopeia (USP) Packaging and Distribution Expert Committee Member.

He holds a Bachelor of Arts degree from Norwich University in Political Science and a Master of Arts degree in Organizational Behavior.
Scott Biggs

Director, Supplier Services

IQVIA
- A3: Biosimilars: Where Are We Now?
- U.S. Pharmaceutical Market and Innovation – What’s In, What’s Out, What’s Ahead
Scott Biggs

Director, Supplier Services

IQVIA
- A3: Biosimilars: Where Are We Now?
- U.S. Pharmaceutical Market and Innovation – What’s In, What’s Out, What’s Ahead
IQVIA is the world’s largest pharmaceutical information company, serving over 101 countries. He has been with IQVIA since 2011. Prior to IQVIA Scott worked for other pharmaceutical information companies for several years and worked at Rite Aid Corporation in multiple roles for over 10 years. Scott received a BS degree from Penn State University in Accounting and has been working with pharmacy data for almost 30 years. In his role at IQVIA Scott has worked with retailers, software vendors and other data suppliers where he has helped them to understand their performance in the marketplace through business reviews and market analysis.
Josh M. Bolin

Associate Executive Director for Government Affairs and Innovation

National Association of Boards of Pharmacy®
- B1: Boards of Pharmacy Perspectives on DSCSA Implementation and Enforcement
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Josh M. Bolin

Associate Executive Director for Government Affairs and Innovation

National Association of Boards of Pharmacy®
- B1: Boards of Pharmacy Perspectives on DSCSA Implementation and Enforcement
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Josh Bolin serves as the Associate Executive Director for Federal Affairs and Strategy for the National Association of Boards of Pharmacy (NABP). Since joining NABP in 2005, Josh has worked on development of PMP InterConnect, multiple pharmacy accreditation and inspection programs, including accreditation programs for durable medical equipment and specialty pharmacy, and inspection programs for the prescription drug supply chain, sterile and nonsterile compounding and nuclear pharmacy. Josh also worked with NABP’s member boards of pharmacy to develop NABP’s Universal Inspection form and Multistate Inspection Blueprint, which are tools to assist the boards of pharmacy in conducting uniform inspections of sterile compounding facilities. Josh is currently working with NABP member boards of pharmacy on uniform processes and tools with respect to the DSCSA.
Andrew Boyle

Chairman, American Trucking Associations & Co-President

Boyle Transportation, an Andlauer Healthcare Group company
- How the Truck is This Gonna Get There?
  Wednesday, March 13, 2024 | 9:00—10:00 AM
Andrew Boyle

Chairman, American Trucking Associations & Co-President

Boyle Transportation, an Andlauer Healthcare Group company
- How the Truck is This Gonna Get There?
  Wednesday, March 13, 2024 | 9:00—10:00 AM
Andrew Boyle is co-president of Boyle Transportation, a firm that provides secure, validated transportation & logistics services to select clients in the biotech/pharmaceutical and government/defense sectors. Boyle is now a subsidiary of Andlauer Healthcare Group, a Toronto Stock Exchange-listed provider of diversified healthcare logistics services. Prior to returning to the company in 2003, Andrew was an investment banker with J.P. Morgan. He earned an MBA from Northwestern University's Kellogg School of Management and an AB from Bowdoin College, where his academic performance was undistinguished and his athletic career was underwhelming.

Andrew is the chair of the American Trucking Associations and a member of the American Transportation Research Institute’s (ATRI) board of directors and of Northwestern University Transportation Center’s business advisory committee. He’s also a trustee of Eastern Bank and serves on boards and committees of several non-profit organizations including House of Hope and The Hole in the Wall Gang Camp. He is a three time winner of the KGC’s “4th Best Looking Man” award.
Randy V. Bradley

Assistant Professor of Information Systems and Supply Chain Management

University of Tennessee
- D1: Beyond 2024: Exploring the Additional Value of DSCSA Data
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Sinatra Ballroom Salons 7
Randy V. Bradley

Assistant Professor of Information Systems and Supply Chain Management

University of Tennessee
- D1: Beyond 2024: Exploring the Additional Value of DSCSA Data
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Sinatra Ballroom Salons 7
Dr. Randy V. Bradley is an Associate Professor of Information Systems and Supply Chain Management in the Haslam College of Business at The University of Tennessee. He is also EVP, Digital Transformation in Life Sciences for Bio Supply Management Alliance (BSMA) and Principal Owner of RV Bradley, LLC. He holds a Ph.D. in Management of Information Technology and Innovation, an M.S. in Management Information Systems, and a B.S. in Computer Engineering, all from Auburn University. Dr. Bradley is a preeminent thought leader and highly sought-after speaker for professional and corporate conferences and events. Dr. Bradley has 20+ years of industry experience as a consultant and healthcare supply chain and IT strategist and researcher. His expertise includes digital business transformation, supply chain digitalization, and the strategic application of business analytics and IT in the supply chain, with an emphasis on the healthcare sector.
Scott Brown

Two Labs Pharma Services
- C3: The Future of Cold Chain Distribution
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Scott Brown

Two Labs Pharma Services
- C3: The Future of Cold Chain Distribution
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Scott brings a strong market research background to the Envision Pharma Group with over 35 years of experience in study design, data analysis, and reporting. At EPG, he has supported projects in cold chain distribution, product launch and medical affairs operations for companies focused on oncology, cardiovascular and rare diseases.
Jason Chou

Vice President - Pharmacy

Ochsner Health
- C3: The Future of Cold Chain Distribution
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Jason Chou

Vice President - Pharmacy

Ochsner Health
- C3: The Future of Cold Chain Distribution
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
As VP of Pharmacy Services, Dr. Chou has oversight of strategies and pharmacy practice for Ochsner Health. Scope for his role includes supporting Ochsner Health’s 40+ hospitals and 350+ health centers across the gulf south. As Vice President of Pharmacy Services, Dr. Chou has responsibility for drug distribution models, medication access, formulary management, technology and automation, compounding services, and 340b oversight. He earned his Bachelor of Science degree in Cell and Structural Biology at The University of Illinois at Urbana-Champaign, his Doctor of Pharmacy degree from The Ohio State University, and his Master of Science from The University of North Carolina at Chapel Hill. Dr. Chou also completed a PGY1 and PGY2 Health System Pharmacy Administration Residency at Wake Forest Baptist Health in Winston-Salem, North Carolina.

Dr. Chou currently serves as a faculty member for the American Society of Health-System Pharmacists (ASHP) Foundation’s Pharmacy Leadership Academy as well as a Board Member for the End Drug Shortages Alliance EDSA.
Ely Colón

Principal Director – AI Decision Sciences and NA Supply Chain & Operations Gen AI Lead

Accenture
- G4: Decoupling Myth from Reality: Artificial Intelligence and Gen AI in the Healthcare Distribution Industry
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 9
Ely Colón

Principal Director – AI Decision Sciences and NA Supply Chain & Operations Gen AI Lead

Accenture
- G4: Decoupling Myth from Reality: Artificial Intelligence and Gen AI in the Healthcare Distribution Industry
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 9
Kevin Cross

Contracts / Chargebacks Manager

Mutual Drug
- G3: Contracts and Chargebacks Roundtable Discussions
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Kevin Cross

Contracts / Chargebacks Manager

Mutual Drug
- G3: Contracts and Chargebacks Roundtable Discussions
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Deedre Daniel

Founder and Entrepreneur

The Interesting Conversations Company
- Escape the Sticky Rut and Embrace Your Interesting Transformation in a Jiff!
  Wednesday, March 13, 2024 | 10:00—11:00 AM
Deedre Daniel

Founder and Entrepreneur

The Interesting Conversations Company
- Escape the Sticky Rut and Embrace Your Interesting Transformation in a Jiff!
  Wednesday, March 13, 2024 | 10:00—11:00 AM
Deedre Daniel founded The Interesting Conversations Company® to help people think creatively, LAUGH, and build stronger bonds with others. Before starting this business, she spent nearly two decades at GEICO, where she rose through the ranks from call center sales associate to head the Affinity Marketing division. Her team was responsible for the marketing strategy for members of over 800 organizations using a $50 million budget. As the director of that division, she was predominantly a "paid professional schmoozer" - attending hundreds of networking events for these organizations each year. She noticed most people struggled to make lasting connections with others at these events. This universal inability to connect inspired her to create a course called How to be More Interesting Than a Cell Phone®. (A book with the same title is coming out soon!) She invented The Very Interesting Game™ to go with the course. One version of the card game is for sale on Amazon.

When COVID-19 arrived, she turned her signature talk and the card game into a virtual experience for team building and remote networking events - helping others boost optimism and get closer despite social distancing. She served as the game show host for more than 100 virtual sessions for private events with players worldwide in under a year. The Very Interesting Game Show® recently received a registered trademark, too!

Deedre is a graduate of Florida Southern College and lives in Lakeland, Florida, with her husband, Robert, their dog, Spartacus, and her active imagination. When she isn't busy making life more interesting, she writes new cards for other versions of her game and works on the 501(c)(3) she founded called T he Big Fat Tip ®. This organization enlists volunteers' help to surprise people working in the service industry with $1,000+ tips. These are Random Acts of Kindness! Deedre has extensive experience speaking at conferences and training in corporate environments and has earned a reputation for having a wild and zany sense of humor. Check out some of her videos on YouTube.
Chester "Chip" Davis, Jr.

President and Chief Executive Officer

Healthcare Distribution Alliance
- Welcome Address
  Monday, March 11, 2024 | 8:00—8:20 AM
  
  - Sinatra Ballroom Salons 7
Chester "Chip" Davis, Jr.

President and Chief Executive Officer

Healthcare Distribution Alliance
- Welcome Address
  Monday, March 11, 2024 | 8:00—8:20 AM
  
  - Sinatra Ballroom Salons 7
Chester “Chip” Davis, Jr., JD, is the President and Chief Executive Office of HDA and President of the HDA Research Foundation. HDA is the national association representing pharmaceutical distributors — the vital link between the nation’s 1,400 manufacturers and nearly 330,000 sites of care. Mr. Davis oversees HDA’s day-to-day
operations and is responsible for ensuring that the organization’s members have a strong advocacy voice in legislation, regulation and policy.

Mr. Davis joined HDA in March 2020 from the Association of Accessible Medicines (AAM), the nation’s leading trade association for manufacturers of generic and biosimilar medicines, where he served as President and Chief Executive Officer since 2015. Prior to AAM, Mr. Davis held leadership roles at the Pharmaceutical Research and Manufacturers of America and AstraZeneca, where in 2007 he was recognized as one of the
inaugural winners of the CEO Leadership Award.

Mr. Davis earned an undergraduate degree in Accounting from the University of Delaware, and a Juris Doctor from the University of Baltimore School of Law.
Ashley Y. DeFlice

Senior Regulatory Affairs Specialist

Henry Schein, Inc.
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Ashley Y. DeFlice

Senior Regulatory Affairs Specialist

Henry Schein, Inc.
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Ashley joined the Regulatory Affairs team at Henry Schein in 2021 and has been in the regulatory space for 8 years. A subject matter expert on the Drug Supply Chain Security Act (DSCSA), Ashley is the lead member of Henry Schein’s core-team for DSCSA implementation as well as a member of HDA’s Traceability Implementation Work Group. She has spoken previously both in-person and virtually regarding DSCSA compliance and how to overcome challenges to implementation within the wholesale distribution community. In addition to DSCSA compliance, Ashley also comes with extensive knowledge in the areas of state licensure for distribution of pharmaceuticals and medical devices, the NABP Drug Distributor Accreditation program, and internal auditing.
Tim Donelon

Director of Serialization & Manufacturing IT Systems

Upsher-Smith Laboratories, LLC
- D3: Addressing NDC Scarcity: Industry Perspectives on FDA’s Proposal
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Springs Ballroom Salon A
Tim Donelon

Director of Serialization & Manufacturing IT Systems

Upsher-Smith Laboratories, LLC
- D3: Addressing NDC Scarcity: Industry Perspectives on FDA’s Proposal
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Springs Ballroom Salon A
Heather Easterling

Senior Managing Consultant, 340B Solutions, Health Systems

McKesson Corporation
- B3: 340B Update
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Springs Ballroom Salon A
Heather Easterling

Senior Managing Consultant, 340B Solutions, Health Systems

McKesson Corporation
- B3: 340B Update
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Springs Ballroom Salon A
Dr. Heather Easterling is a Senior Managing Consultant for 340B Solutions at McKesson. Her primary responsibilities include engaging with health system customers to optimize their 340B program and implementing McKesson 340B strategy.

Prior to McKesson, Dr. Easterling served as the System Administrative Officer of Pharmacy Services at MUSC Health in Charleston, SC, Clinical Associate Dean of Medical Center Affairs for the MUSC College of Pharmacy, and Director of Pharmacy Graduate Education for residency programs.

Dr. Easterling earned her Doctor of Pharmacy from the Medical University of South Carolina College of Pharmacy and a Master’s in Business Administration from The Citadel Graduate College. She also completed a 24-month pharmacy practice management residency.

Dr. Easterling’s main area of experience is in health system pharmacy operations and promoting the profession through expansion of clinical pharmacy services. She has extensive knowledge of the 340B program and using the program’s benefit to promote health care services to the underserved.
Charles H. Forsaith

Vice President, PCSC

Healthcare Distribution Alliance
- A4: Pharmaceutical Cargo Security Coalition Update
  Monday, March 11, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 9
Charles H. Forsaith

Vice President, PCSC

Healthcare Distribution Alliance
- A4: Pharmaceutical Cargo Security Coalition Update
  Monday, March 11, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 9
Chuck Forsaith is the Vice President of the Healthcare Distribution Alliance’s Pharmaceutical Cargo Security Coalition (PCSC), which offers supply chain security intelligence; access to contacts from industry, government, and vendor trade disciplines; as well as education opportunities to its membership. The Coalition, which Forsaith formed in 2006, brings together professionals from a wide variety of disciplines, to monitor the security of pharmaceutical goods in transit and storage, all over the world. The PCSC became part of HDA in 2017.
Forsaith has been involved in pharmaceutical supply chain security for more than 20 years, following a career as both a New Hampshire municipal and State Police officer. He also, directed security operations for a United States military intelligence gathering installation.

He has lectured both domestically and internationally in the disciplines of supply chain and site security for such organizations as the Department of Justice, the Federal Bureau of Investigation, the U.S. Food and Drug
Administration, the Drug Enforcement Administration, the Department of Homeland Security, the Central Intelligence Agency, United States Customs, the United States Merchant Marine Academy, the Partnership for Safe Medicines, ASIS and TAPA. He is an active member of the American Society of Industrial Security, the Transported Asset Protection Association, the Overseas Security Advisory Council and the National Association of Drug Diversion Investigators.

Forsaith has either authored articles for, or been featured in articles published in The New York Times, The Wall Street Journal, the UK's London Times, Germany's Frankfurter Allgemeine Zeitung, the Financial Times, Business Week, American Shipper, Security Info Watch, Life Science Reader, Security Technology Executive, Cargo Security International and Homeland Security Today.
Kristen L. Freitas

SVP, Federal Government Affairs and Alliance Development

Healthcare Distribution Alliance
- A2: Empowering Advocacy: Navigating PACs, Crafting Messages and Insider Insights from Capitol Hill
- B2: State of the Union: 2024 Federal Policy Outlook
Kristen L. Freitas

SVP, Federal Government Affairs and Alliance Development

Healthcare Distribution Alliance
- A2: Empowering Advocacy: Navigating PACs, Crafting Messages and Insider Insights from Capitol Hill
- B2: State of the Union: 2024 Federal Policy Outlook
Kristen L. Freitas is HDA’s SVP, Federal Government Affairs and Alliance Development. She is responsible for federal legislative advocacy where she develops and maintains relationships with key congressional legislators and their staff, as well as conducts direct lobbying in support of association policies and positions. Kristen also is responsible for fostering relationships with supply chain stakeholders to develop alliances supporting safe and reliable healthcare distribution in the U.S. Further, Kristen oversees the HDA Political Action Committee (PAC) and grassroots activities.

Prior to joining HDA, Freitas worked as Manager, Government Affairs for PacifiCare Health Systems, and before that, for a specialty nursing association and for the National Association for Chain Drug Stores (NACDS). Prior to NACDS, she served as a Director of Outreach for a former Member of Congress.

She holds a degree in International Relations from Michigan State University and a Master of Public Administration (MPA) from George Mason University.
Perry L. Fri

Executive Vice President, Industry Relations & Member Services and COO, HDA Research Foundation

Healthcare Distribution Alliance
- Morning General Session
  Tuesday, March 12, 2024 | 8:15—9:30 AM
  
  - Sinatra Ballroom Salons 7
Perry L. Fri

Executive Vice President, Industry Relations & Member Services and COO, HDA Research Foundation

Healthcare Distribution Alliance
- Morning General Session
  Tuesday, March 12, 2024 | 8:15—9:30 AM
  
  - Sinatra Ballroom Salons 7
Perry L. Fri is HDA’s Executive Vice President of Industry Relations, Membership & Education and Chief Operating Officer of the HDA Research Foundation. At HDA, Fri is responsible for the direction, supervision and development of industry initiatives that facilitate improved business processes and operational efficiencies in the healthcare supply chain. Fri currently serves on the Board of Directors for Healthcare Ready, a 501(c)(3) organization established to help public and private sector stakeholders across the pharmaceutical supply chain prepare for (and maintain operations during) disasters.

Fri previously served as Vice President of Industry Relations and Program Development for the Health Industry Distributors Association (HIDA). Prior to joining HIDA, Fri held positions with The Hale Group and Instill Corporation. He holds a BA in History from the University of Maryland.
Michael Ganio

Senior Director, Pharmacy Practice and Quality

ASHP Foundation
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Michael Ganio

Senior Director, Pharmacy Practice and Quality

ASHP Foundation
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Dr. Ganio is Senior Director of Pharmacy Practice and Quality at the American Society of Health-System Pharmacists. As a member of the ASHP Center on Medication Safety and Quality, his responsibilities span the practice of pharmacy and include drug shortages, sterile and non-sterile drug compounding practices, and hazardous drug safety.

Dr. Ganio earned his Pharm.D. from Rutgers University Ernest Mario School of Pharmacy, and his master’s degree in health-system pharmacy administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center.

As a member of ASHP staff, Dr. Ganio has been an advocate for the advancement of pharmacy practice as a liaison to several federal agencies and healthcare organizations. He is a recognized expert on drug shortages and has represented pharmacists and patients at several meetings, including with the Executive Office of the President and as an expert witness testifying before Congress.
John A. Gilbert

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salon 6
John A. Gilbert

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salon 6
John Gilbert is a Director with the law firm of Hyman, Phelps & McNamara, P.C. The firm advises and represents a broad range of clients on legal issues concerning food, drug, medical devices, biologicals, pharmacy and cosmetic law and regulation.

Mr. Gilbert advises clients extensively on legal and regulatory issues concerning controlled substances, prescription drugs and precursor chemicals. His expertise extends to all regulatory and enforcement areas on federal and state laws and regulations governing the scheduling, manufacturing, distribution, dispensing, import and export of drugs and chemicals. He has extensive knowledge of the relationship and interaction of the federal Controlled Substances Act (CSA) and state laws governing controlled substances and precursor chemicals.
Rena K. Goins

Executive Director, Global Trade & Distribution

Regeneron Healthcare Solutions
- C3: The Future of Cold Chain Distribution
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Rena K. Goins

Executive Director, Global Trade & Distribution

Regeneron Healthcare Solutions
- C3: The Future of Cold Chain Distribution
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Rena K. Goins is a 25+year veteran of the specialty marketplace working across a host of roles supporting patients, providers and pharma. Her past roles with specialty distributors Cardinal Health, McKesson, and Metro Medical provided extensive experience supporting pharma launches and helping embed technologies like inventory control, claims analysis tools, and, EMR systems into specialty offices. Rena has worked in oncology, vaccines, nephrology, rheumatology, immunology, ophthalmology and many other specialty markets. She has managed GPOs and contract pricing, helped build specialty pharmacies, and served as a payer account manager. In her current role at Regeneron she’s preparing for everything from rare disease launches, to pandemic therapies, chronic disease products, and all the trade needs along that continuum. Her work supporting the distribution of monoclonal antibody therapy, REGEN-COV™, earned her and the Regeneron team a DIANA award from HDA.
Stacey Gordon

CEO

Rework Work
- B4: Inclusion Without ‘I’ Doesn’t Make Sense
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 9
Stacey Gordon

CEO

Rework Work
- B4: Inclusion Without ‘I’ Doesn’t Make Sense
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 9
As an Executive Advisor and Inclusive Workplace Culture Consultant, Stacey Gordon anchors action using change management principles while facilitating mindset shifts. She combines concepts of recruiting, career development, diversity and workplace culture to focus on reworking how companies work; including how they inclusively recruit, hire and engage employees, effectively creating inclusion and belonging for all. Through her company, Rework Work, she has worked with executive leaders and people managers from companies such as American Express, Kia Motors, Hewlett Packard, GE, Roku, The Obama Foundation and many others to deliver education, coaching and consulting that supports organizational change and leadership development in furtherance of creating inclusive workplace cultures.

As a globally recognized keynote speaker, leadership consultant and DEI strategist, Stacey has provided subject matter expertise to Harvard Business Review, SHRM, Fast Company, Skillsoft, Forbes, NPR and BBC Radio.

Stacey’s book, UNBIAS: Addressing Unconscious Bias at Work debuted at #1 on Amazon’s Hot New Release list while her unconscious bias course on the LinkedIn learning platform was the #1 most watched course of 2021 and has been translated into several languages. Her audience is quickly approaching 2 million unique learners and Stacey has been recognized as a passionate supporter of DEI by Forbes, the Los Angeles Times, Pepperdine University and LinkedIn. She earned her MBA from Pepperdine University Business School and her SHRM-SCP certification, as well as the SHRM Inclusive Workplace Culture Credential. To learn more visit learn.reworkwork.com.
Gregg A. Gorniak

VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead

Cencora, Inc.
- F1: Exceptions Handling: Mitigating and Correcting Data Errors to Keep Products Moving During the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Gregg A. Gorniak

VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead

Cencora, Inc.
- F1: Exceptions Handling: Mitigating and Correcting Data Errors to Keep Products Moving During the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Gregg is currently Vice President – Manufacturer Operations & Data Services and Secure Supply Chain Lead for Cencora (formerly AmerisourceBergen). The SSC project team is delivering the Track & Trace and serialization requirements of the DSCSA. Gregg’s focus is currently on Manufacturer & Customer onboarding activities as well as DC activation for inbound scanning at receiving, returns, and exception handling while also sending outbound EPCIS messages to downstream trading partners.

Prior to AB, Gregg was the US Serialisation Lead at GSK leading the work on the DSCSA saleable returns project and developing GSK’s long-term solution for the DSCSA requirements in 2023. At GSK, Gregg held positions ranging from Analytics Reporting Manager in R&D Clinical Operations, Data Lead for the US SAP implementation, and Director of Data Quality in the Transparency Data Operations & Reporting team in Pharma Finance. Prior to GSK, Gregg worked for 6 years at Pfizer in Global Logistics & Supply in the Enterprise Data Management group focused on SAP Material Master.

Gregg has almost 25 years of experience in multiple Leadership & Senior Data roles in both the Pharmaceutical, Finance, and Software industries. Gregg holds an MBA in Management from Saint Joseph’s University’s Haub School of Business and a BS in Business Administration from Rider University. Gregg has a passion for data, systems, & business processes and strives to work towards solutions that benefit all.
Kim Grinston

Executive Director

Missouri Board of Pharmacy
- B1: Boards of Pharmacy Perspectives on DSCSA Implementation and Enforcement
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Kim Grinston

Executive Director

Missouri Board of Pharmacy
- B1: Boards of Pharmacy Perspectives on DSCSA Implementation and Enforcement
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Kimberly Grinston, J.D., has served as Executive Director of the Missouri Board of Pharmacy since January 2008. Kimberly has been a licensed attorney for over 25 years, and has vast experience in regulatory, administrative, constitutional, and employment discrimination law. Ms. Grinston previously served as a Missouri Assistant Attorney General, Senior Legal Counsel for the Missouri Department of Commerce and Insurance (formerly the Missouri Department of Insurance), and Legal Counsel for the Division of Professional Registration.
Mark J. Hardy

Executive Director

North Dakota Board of Pharmacy
- B1: Boards of Pharmacy Perspectives on DSCSA Implementation and Enforcement
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Mark J. Hardy

Executive Director

North Dakota Board of Pharmacy
- B1: Boards of Pharmacy Perspectives on DSCSA Implementation and Enforcement
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Dr. Mark Hardy, Pharm D is the Executive Director of the ND Board of Pharmacy. Mark is a native of Neche, ND and a 2007 graduate of the North Dakota State University College of Pharmacy where he earned his Doctor of Pharmacy Degree.

On behalf of the Board of Pharmacy, Dr Hardy ensures the public safety by supervising licensing of pharmacists, pharmacies, pharmacy technicians, prescription drug wholesalers and manufacturers; establishing policies and regulations for the practice of pharmacy. He also is responsible for the operation of the state of North Dakota’s Prescription Drug Monitoring Program, which facilitates controlled substance information to help identify and inhibit diversion in an efficient and cost-effective manner.

Mark has been active in the profession of pharmacy in North Dakota serving in leadership positions with the NDSU School of Pharmacy and the ND Pharmacist Association. Mark previously served as the chair of the Prescription Monitoring Program Interconnect committee which fosters interstate sharing of data between PMPs. Mark has been active within the National Association of Boards of Pharmacy serving on Task Forces, participating in multiple work groups and providing presentations of his experiences. Mark has been recognized by his peers with the 2022 NABP Lester E. Hosto Distinguished Service Award, the Horizon Award from the NDSU Alumni Association, and the Pharmacist Mutual Insurance Distinguished Young Pharmacist.
Scott T. Hatakeyama

Director, Inventory Management and Optimization

Kaiser Permanente
- E1: Dispenser Perspectives on the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 7
Scott T. Hatakeyama

Director, Inventory Management and Optimization

Kaiser Permanente
- E1: Dispenser Perspectives on the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 7
Scott Hatakeyama proudly represents Kaiser Permanente. Contributing to their quest to deliver high-quality, affordable healthcare, Scott leads the DSCSA implementation team. With more than 15 years of healthcare and systems experience, Scott is charged with implementing a robust, standardized and cost-effective solution to keep Kaiser Permanente in compliance today through 2023 and beyond.
Carla Howard

Mentor

The Professional Woman's Mentor LLC
- D4: Emerging Leaders Session: Elevating Your Career with Candid Conversations
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Sinatra Ballroom Salons 9
Carla Howard

Mentor

The Professional Woman's Mentor LLC
- D4: Emerging Leaders Session: Elevating Your Career with Candid Conversations
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Sinatra Ballroom Salons 9
Carla has served as a trusted advisor and mentor for over two decades. Her background includes experience leading successful transformational change, coaching professionals to achieve their personal and business goals, and gracefully navigating office politics. She understands the challenges facing professionals in the workplace today, and is passionate about helping her clients take charge of their careers and become more strategic thinkers.
Courtney Johnson

Vice President, Specialty Distribution

Two Labs Pharma Services
- C3: The Future of Cold Chain Distribution
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Courtney Johnson

Vice President, Specialty Distribution

Two Labs Pharma Services
- C3: The Future of Cold Chain Distribution
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Springs Ballroom Salon A
Courtney joined Two Labs in 2020 to help commercial, trade, and market access teams assess their needs in launching a new product into the specialty channel. Courtney has helped launch more than 200 specialty products over the last seven years, and she's a go-to expert on Specialty Distribution, including oncology, urology, retina, gastroenterology, neurology, and nephrology. She is an expert in exclusive distribution modeling and supports cell & gene, wholesale, and generic engagements.
Michelle L. Keller

VP Commercial Operations

Teva Pharmaceuticals
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Michelle L. Keller

VP Commercial Operations

Teva Pharmaceuticals
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Michelle Keller is Vice President of Commercial Operations at Teva Pharmaceuticals and has been with the company for 20 years. Michelle began her Teva journey in Manufacturing Operations, transitioning to Supply Chain and ultimately Commercial where she is now responsible for customer-facing supply and operational decisions, along with the overall management of Teva’s inline generics portfolio. Michelle has spent her career focusing on subjects including supply chain and operational excellence, drug supply chain security, and other strategic and operational topics related to service and supply of pharmaceuticals to the US Market. Michelle earned a MBA from DeSales University, and holds a B.S. in Ceramic Engineering from Rutgers University.
Melissa Kellstrom

Executive Assistant, DEA Diversion Control Division

U.S. Drug Enforcement Administration (DEA)
- E2: Discussion with the Drug Enforcement Administration
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salon 6
Melissa Kellstrom

Executive Assistant, DEA Diversion Control Division

U.S. Drug Enforcement Administration (DEA)
- E2: Discussion with the Drug Enforcement Administration
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salon 6
Mark Klawitter

Board Inspector

Montana Board of Pharmacy
- B1: Boards of Pharmacy Perspectives on DSCSA Implementation and Enforcement
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Mark Klawitter

Board Inspector

Montana Board of Pharmacy
- B1: Boards of Pharmacy Perspectives on DSCSA Implementation and Enforcement
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Mark has been an inspector with the Montana Board of Pharmacy since August 2018. He started his career in Nome, AK, after graduating from the University of Montana. From there, he continued as director of pharmacy services in hospitals in California and Oregon. He returned to Montana to practice retail pharmacy as a manager for 21 years prior to joining the Board.
Blair Korman

Sr. Director, Digital Identification & Traceability

Johnson & Johnson Supply Chain
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Blair Korman

Sr. Director, Digital Identification & Traceability

Johnson & Johnson Supply Chain
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Blair Korman is the Senior Director of Digital Identification & Traceability for Johnson & Johnson. She leads the delivery of critical enterprise capabilities in the areas of regulatory compliance, customer compliance, standards and emerging digital technologies. She focuses her efforts on uniting the digital thread with the physical product and providing easier access to more accurate and more timely product data. Blair has more than two decades of supply chain expertise spanning operations, customer engagement and interactions with regulatory agencies and industry associations. She holds a Bachelor of Science in industrial and systems engineering from Virginia Tech and a Master of Science in engineering management from the University of South Florida.
Abha Kundi

Team Lead in the Office of Drug Security, Integrity and Response

U.S. Food and Drug Administration
- A1: FDA DSCSA Overview and Update
  Monday, March 11, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 7
Abha Kundi

Team Lead in the Office of Drug Security, Integrity and Response

U.S. Food and Drug Administration
- A1: FDA DSCSA Overview and Update
  Monday, March 11, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 7
Abha Kundi is a Team Lead in the Office of Drug Security, Integrity, and Response in FDA’s Center for Drug Evaluation and Research, Office of Compliance. For over a decade, her work at FDA has focused on the development of policies and regulatory strategies to improve the security and integrity of the U.S. drug supply. Abha received both her law degree and master’s degree in public health from Boston University.
Leah D. Lindahl

Vice President, State Government Affairs

Healthcare Distribution Alliance
- C2: State of the States
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Leah D. Lindahl

Vice President, State Government Affairs

Healthcare Distribution Alliance
- C2: State of the States
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Leah Lindahl is Vice President of State Government Affairs for HDA. In this role, Lindahl provides leadership and oversight for HDA’s state legislative and regulatory activities, advocating for sound public policy that supports patient access to medicines and medical products through safe, efficient and effective distribution. Previously, she covered a 19-state region across the western U.S., most recently as Senior Director of State Government Affairs.

Prior to joining HDA in 2016, Lindahl was the Vice President of the Colorado BioScience Association (CBSA). In this role, Lindahl ensured the bioscience industry was represented to its fullest potential by managing the association’s strategic planning and implementation of public policy initiatives on the state and federal level, sponsorship retention and expansion, program planning and overall membership development activities. Before joining CBSA, Lindahl was an account executive with The Kenney Group, a regional political consulting firm, where she managed healthcare, patient advocacy and the life science industry.

Lindahl earned a bachelor's degree in Journalism and Political Science from Colorado State University.
Nicolette Louissaint

Senior Vice President, Policy and Strategic Planning

Healthcare Distribution Alliance
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Nicolette Louissaint

Senior Vice President, Policy and Strategic Planning

Healthcare Distribution Alliance
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Dr. Nicolette Louissaint serves as the Senior Vice President for Policy and Strategic Planning for the Healthcare Distribution Alliance (HDA). In this role, she leads HDA’s efforts to build policies and strategic approaches to bolster supply chain resilience and reinforce the role of healthcare distributors in the healthcare ecosystem.

She previously served as the Executive Director and President of Healthcare Ready, a 501(c)(3) organization that focuses on strengthening the United States’ healthcare supply chain preparedness and response before, during and after natural disasters and disease pandemics. Under her leadership, Healthcare Ready strengthened its position as a facilitator and coordinator that improves our nation's ability to plan for and respond to threats that disrupt patient access to healthcare during crises, including COVID-19.

Prior to this, Dr. Louissaint served as the Senior Advisor to the U.S. Department of State’s Special Coordinator for Ebola during the height of the 2014 epidemic. In this role, she was responsible for coordinating international efforts and jumpstarted the diplomatic response to the epidemic. Earlier in her career, Nicolette served as a Foreign Affairs Officer in the U.S. Department of State’s Bureau of Economic and Business Affairs. As the lead officer for health intellectual property and trade issues, she developed on policies and strategies related to pharmaceutical counterfeiting, pharmaceutical trade, supply chain, climate change and other science and technology development issues.

Dr. Louissaint previously served on the Federal Emergency Management Agency’s National Advisory Council in 2019 and chaired the Equity Working Group. Her current roles also include serving on Baltimore City’s Sustainability Commission, as a board member of Project HOPE, and as a Co-Chair of theHealthcare and Public Health Sector Coordinating Council. In 2020, Dr. Louissaint was named one of The Root 100 Most Influential African Americans.

She earned her bachelor’s degrees in Chemical Engineering and Biological Sciences from Carnegie Mellon University, a PhD in Pharmacology and Molecular Sciences from Johns Hopkins University School of Medicine, and an MBA from the University of Baltimore. She completed post-doctoral fellowships at the Johns Hopkins University and the American Association for the Advancement of Science.
David G. Mason

Supply Chain Compliance and Serialization Lead

Sandoz
- F1: Exceptions Handling: Mitigating and Correcting Data Errors to Keep Products Moving During the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
David G. Mason

Supply Chain Compliance and Serialization Lead

Sandoz
- F1: Exceptions Handling: Mitigating and Correcting Data Errors to Keep Products Moving During the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Dave Mason is currently the Director of Supply Chain compliance and Serialization – Dave supports the Commercial Trade and Supply Chain teams, supporting the implementation of DSCSA for the Novartis group. Leading efforts to assure Novartis error rates are six sigman or less by assuring procedures are in place for serialization data quality and integrity, improving existing serialization processes and systems as information is provided by supply chain partners on the DSCSA processes. Dave represents Novartis in trade association, PDG and FDA public meetings. He communicates to the NTO Global Serialization team with new and existing requirements for other countries, and he assures that the validation approach is consistent within the organization and execution at the sites. Dave also supports the team to develop to support serialization as it is integrated into the normal business processes. Dave has worked on serialization since 2003 in California and helped implement global solutions.
Michael J. Mazur

Director, Trade Operations

Pfizer Inc.
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Michael J. Mazur

Director, Trade Operations

Pfizer Inc.
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Mike’s responsibilities include developing and implementing strategies to enhance patient safety and further secure the U.S. pharmaceutical supply chain. He represents Pfizer externally on various customer engagements and industry interactions relative to channel security and works closely with internal Pfizer colleagues to implement approved strategies. Mike has been directly involved with Pfizer’s global projects to implement serialization and is responsible for ensuring compliance with the U.S. Drug Supply Chain Security Act (DSCSA) requirements. He also works closely with Pfizer’s Global Security organization as it relates to investigations of suspected counterfeit or adulterated Pfizer products and is a member of the GS1 Healthcare US. Mike has 22 years of operational experience within the pharmaceutical industry.
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Scott Mooney is Vice President of Distribution Operations at McKesson Corporation. His primary responsibilities are assuring product integrity through regulatory compliance and traceability. Scott leads McKesson’s Traceability Team working on implementation across McKesson’s various business units.

Scott joined McKesson in 1987 and had previous roles in Finance, Distribution Center Management and as a Regional Vice President of Distribution Operations. Scott has participated in McKesson’s integration of acquisitions over the last 16 years.

Scott has been active in HDA’s Traceability Workgroup, the HDA Industry Relations Council and participates in several committees including the FGAC, RAC and SGAC. He is tri-chair of GS1 Global Healthcare Leadership Team and is a member of the GS1 US Healthcare Executive Leadership Committee.

Scott has a BA in Accountancy and a MBA from the University of Wisconsin – La Crosse.
Tracy Nasarenko

Vice President of Community Engagement, Healthcare

GS1 US
- D3: Addressing NDC Scarcity: Industry Perspectives on FDA’s Proposal
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Springs Ballroom Salon A
Tracy Nasarenko

Vice President of Community Engagement, Healthcare

GS1 US
- D3: Addressing NDC Scarcity: Industry Perspectives on FDA’s Proposal
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Springs Ballroom Salon A
Tracy Nasarenko, vice president of Community Engagement at GS1 US for Healthcare, is an accomplished leader with more than 20 years of experience in healthcare and pharmaceutical supply chain, finance, product management, marketing, and operations.

In her current role, Ms. Nasarenko leads a collaborative healthcare industry group focused on addressing supply chain challenges and meeting the requirements of regulations like the Drug Supply Chain Security Act (DSCSA). Using GS1 Standards, the most widely used supply chain standards in the world, Ms. Nasarenko guides the implementation of these standards to help the pharmaceutical industry deliver safe products to patients.

Prior to joining GS1 US, Ms. Nasarenko held several leadership positions with SPI Pharma Inc. Most recently, she served as a site general manager, overseeing end-to-end operations and performance of the entire team, where she built a culture of engagement, innovation, and collaboration.

Ms. Nasarenko earned her bachelor’s degree from Villanova University and received her Master of Business Administration from West Chester University.
Maryann Nelson

Regulatory Manager

Cardinal Health, Inc.
- F1: Exceptions Handling: Mitigating and Correcting Data Errors to Keep Products Moving During the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Maryann Nelson

Regulatory Manager

Cardinal Health, Inc.
- F1: Exceptions Handling: Mitigating and Correcting Data Errors to Keep Products Moving During the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Maryann Nelson is a Regulatory Manager with Cardinal Health, Inc. responsible for developing strategies to insure supply chain integrity, preventing prescription drug diversion and complying with state and federal legislative requirements. She has over 30 years of experience in Pharmaceutical Distribution. She is actively involved with industry organizations, including HDA and GS1, focused on implementing the Track and Trace requirements of the Drug Supply Chain Security Act (DSCSA).

Ms. Nelson is a graduate of The Pennsylvania State University where she received a BS degree in Business Logistics.
Leon Nevers

Senior Director, Procurement and Business Development

H-E-B
- D3: Addressing NDC Scarcity: Industry Perspectives on FDA’s Proposal
- E1: Dispenser Perspectives on the DSCSA Stabilization Period
Leon Nevers

Senior Director, Procurement and Business Development

H-E-B
- D3: Addressing NDC Scarcity: Industry Perspectives on FDA’s Proposal
- E1: Dispenser Perspectives on the DSCSA Stabilization Period
Leon Nevers is the Director of Procurement and Business Development with H-E-B Pharmacy. Leon has been engaged in retail buying and selling for a lifetime. He actively works with suppliers, employers, state and U.S. political leaders, and a variety of health care providers to provide lifestyle changes that keep Texans healthy at H-E-B.

Leon has managed direct relationships with hundreds of H-E-B suppliers of Rx, OTC, and Home Diagnostics controlling an annual budget of over $2 billion per year. He currently is Chairman of The Buyers Consortium, LLC, representing 1200 retail stores and $1 billion in Generics Purchasing opportunity with group contracting. He directs, trains, and coaches business development experts to support all aspects of procurement, immunizations, store communications, third party reimbursement, specialty pharmacy, medication therapy management and helps form strategies for business development and buying.

With extensive experience in both the pharmacy and retail industries, Leon looks for simple solutions that can make life long health improvements in a value market. He believes in serving others as a formula for personal success.
Steven Noetzel

Senior Director, Trade Strategy & Distribution

Johnson & Johnson Health Care Systems Inc.
- D3: Addressing NDC Scarcity: Industry Perspectives on FDA’s Proposal
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Springs Ballroom Salon A
Steven Noetzel

Senior Director, Trade Strategy & Distribution

Johnson & Johnson Health Care Systems Inc.
- D3: Addressing NDC Scarcity: Industry Perspectives on FDA’s Proposal
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Springs Ballroom Salon A
Tish E. Pahl

Principal

Olsson Frank Weeda Terman Matz PC
- G1: FDA’s Final DSCSA Guidance: HDA Review and Compliance Considerations
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Tish E. Pahl

Principal

Olsson Frank Weeda Terman Matz PC
- G1: FDA’s Final DSCSA Guidance: HDA Review and Compliance Considerations
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Tish Eggleston Pahl is a principal at Olsson Frank Weeda Terman Matz PC. She is regulatory counsel to drug, cosmetic, dietary supplement and food clients with concerns before the Food and Drug Administration, the Federal Trade Commission, and other federal agencies. Her work has encompassed representation of companies making and marketing human and animal prescription and over-the-counter (OTC) drugs, dietary supplements, and cosmetics. She has particular expertise in the areas of health care communications, advertising and labeling of FDA-regulated products. Further, she advises trade association clients on a range of antitrust and trade regulation issues.

Since November 2013, Tish has been heavily involved with implementation of the Drug Quality and Security Act (DQSA). She has advised pharmacy compounders and outsourcing facilities on their new FDA responsibilities under Title I of the DQSA. She has worked closely with pharmaceutical supply chain stakeholders, including manufacturers, repackagers, and wholesale distributors, on implementation of Title II of the DQSA, the Drug Supply Chain Security Act (DSCSA).

Tish is a regular participant in HDA activities, providing FDA regulatory and antitrust counsel to the Public Policy Council, the Traceability Implementation Work Group, the Regulatory Affairs Committee, the Returns Task Force, and other committees.

Tish graduated from Northwestern University and earned her Juris Doctor from Northwestern University (cum laude).
Karla Palmer

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salon 6
Karla Palmer

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salon 6
With over 25 years’ experience as a litigator, Karla’s focus at Hyman Phelps is on DEA and FDA enforcement and litigation matters. Karla also advises clients throughout the supply chain - from manufacturers and distributors to outsourcing facilities, pharmacies and doctors - on a range of issues including DEA and FDA regulations and guidance, government inspections (including Form 483s) and investigations, warning letters, consent decrees, and administrative and federal proceedings. In addition, she has written about and addressed industry audiences on all aspects of the passage and implementation of the 2013 Drug Quality and Security Act including both compounding and supply chain issues, its guidance documents, and implementing regulations. She is well-versed on the DSCSA and on compounding laws, regulations and guidance, and regularly counsels clients throughout the nation on these matters.
Brandy Porter

Assistant Center Director - Enforcement Pharmaceuticals, Health, and Chemicals Center of Excellence and Expertise

U.S. Customs and Border Protection
- C4: The Customs and Border Protection (CBP) Pharmaceutical Center of Excellence and Registering Your Products with CBP
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 9
Brandy Porter

Assistant Center Director - Enforcement Pharmaceuticals, Health, and Chemicals Center of Excellence and Expertise

U.S. Customs and Border Protection
- C4: The Customs and Border Protection (CBP) Pharmaceutical Center of Excellence and Registering Your Products with CBP
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 9
Brandy Porter is the Assistant Center Director for the Pharmaceuticals, Health, and Chemicals (PHC) Center of Excellence and Expertise for U.S. Customs and Border Protection (CBP). She oversees PHC’s enforcement division, focusing on identifying high risk areas and mitigating them using the full range of CBP’s enforcement capabilities.

In 2021, Ms. Porter became a Deputy Assistant Director of Field Operations, for the Center for Intelligence, Targeting, and Enforcement in the NYFO. She led a team of CBP Officers, Enforcement Analysis Specialists and Intelligence Research Specialists focused on the wide range of mission sets affecting the New York Field Office.

Ms. Porter began her career with U.S. Customs and Border Protection in 2009. She received B.S. in Intelligence and Security Studies from Embry-Riddle Aeronautical University in 2003 and a master’s degree in Middle East Studies from the American University in Cairo in 2009. She currently lives in Long Beach, CA.
Thomas W. Prevoznik

Assistant Administrator, Diversion Control Division

U.S. Drug Enforcement Administration (DEA)
- E2: Discussion with the Drug Enforcement Administration
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salon 6
Thomas W. Prevoznik

Assistant Administrator, Diversion Control Division

U.S. Drug Enforcement Administration (DEA)
- E2: Discussion with the Drug Enforcement Administration
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salon 6
Acting Assistant Administrator (DAA) Thomas W. Prevoznik began his career with the Drug Enforcement Administration (DEA) in February 1991. Upon his graduation from Basic Diversion Investigator Training, DAA Prevoznik was assigned as a Diversion Investigator (DI) to the Philadelphia Field Division. After serving in many supervisory roles in the Philadelphia Field Division, New Jersey Field Division, and DEA Headquarters, in August 2019, he was promoted to the Senior Executive Service as DAA of the Diversion Control Division.

DAA Prevoznik is a graduate from the University of Notre Dame, with a Bachelor of Arts in 1987; and the University of Virginia, with a Masters in Adult Education in 2004.
Andrew Rahimi

Technical Lead

True North Group LLC
- F4: Cyber Resiliency to Keep Freight Moving: Case Studies in Marine Transportation Cybersecurity and the Journey to Resilience
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 9
Andrew Rahimi

Technical Lead

True North Group LLC
- F4: Cyber Resiliency to Keep Freight Moving: Case Studies in Marine Transportation Cybersecurity and the Journey to Resilience
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 9
Andrew has 25 years of IT experience, including 12 years of professional cybersecurity experience. Prior to joining True North, Andrew spent four years at CLEAR Secure Inc, where he supported three distinct avenues of the business: Product Security, Product Innovation, and Product Operations. As CLEAR’s first Product Security hire, Andrew was responsible for building application security, cloud security, vulnerability management, and penetration testing programs from the ground-up, as well as maintaining strict compliance with NIST 800-53 “FISMA High” standards, and interfacing with regulators at TSA/DHS. After developing specialized expertise in hardening a fleet of over 3000 kiosk computers running the Microsoft Windows operating system (and CLEAR enrollment/verification software), Andrew played an instrumental role in the system architecture for two new products from CLEAR: TSA PreCheck by CLEAR, and Health Pass by CLEAR. For his remaining tenure at CLEAR, Andrew supported the operations for all CLEAR products, with a focus on streamlining and securing the software supply chain across both open-source dependencies and closed-source commercial software (as a service) vendors.

Prior to CLEAR, Andrew spent seven years as a penetration tester with NCC Group, serving repeat customers across verticals such as: banking, retail, automotive + aerospace engine manufacturing, social media, wireless (cellular), and (public) cloud. Prior to NCC Group, Andrew was a researcher for iSEC Partners, where he was responsible for developing and responsibly disclosing exploits that allowed for the wiretapping of calls, text messages, and mobile data sessions belonging to arbitrary Verizon Wireless customers. Andrew demonstrated these exploits at Black Hat & Defcon conferences in 2013 in Las Vegas. Andrew holds a Computer Science degree from Bucknell University and is a proud alum of the FIRST Robotics Competition.
Senthil S. Rajaratnam

Senior Director, Global Serialization and UDI

Lilly USA, LLC
- F1: Exceptions Handling: Mitigating and Correcting Data Errors to Keep Products Moving During the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Senthil S. Rajaratnam

Senior Director, Global Serialization and UDI

Lilly USA, LLC
- F1: Exceptions Handling: Mitigating and Correcting Data Errors to Keep Products Moving During the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 7
Senthil Rajaratnam is the Director for Global Serialization and UDI implementation. In his role, Senthil leads the global strategy and implementation for serialization and product traceability for pharmaceutical products and Unique Device Identification implementation for medical devices. Senthil coordinates with the Lilly’s affiliate offices, packaging sites, engineering and IT teams to implement the right solutions to ensure compliance with serialization/UDI marking and reporting requirements.

Senthil has been with Eli Lilly and Company for 20 years. Senthil’s key expertise includes packaging line equipment and systems, warehousing, distribution and logistics area of the supply chain and has deep knowledge in the business processes and solutions in this space. He is also the subject matter expert on GS1 standards and is part of various industry workgroups that work towards a common goal of providing advocacy to influence the adoption of global standards, harmonizing requirements and help governments achieve their goals leveraging serialization. He is currently on the Board of Directors for Partnership for DSCSA Governance (PDG) and also part of the Healthcare Leadership team of GS1 Healthcare Global organization.
Dr. Samuel Ramsey

Inspirational Changemaker in Science & Society; Cutting-Edge Communicator; Founder & Director

Ramsey Research Foundation
- The Power of Peculiar Thinking: Problem-Solving Through Creativity and Ingenuity.
  Tuesday, March 12, 2024 | 8:30—9:30 AM
Dr. Samuel Ramsey

Inspirational Changemaker in Science & Society; Cutting-Edge Communicator; Founder & Director

Ramsey Research Foundation
- The Power of Peculiar Thinking: Problem-Solving Through Creativity and Ingenuity.
  Tuesday, March 12, 2024 | 8:30—9:30 AM
One of only a handful of African Americans to earn a PhD in entomology, Dr. Sammy Ramsey is an inspirational science leader and communicator who has defied the odds to achieve his dreams and is a testament to the power of grit, determination, and an unwavering commitment to one’s purpose. When people said he didn’t have what it took to make his mark in entomology, he proved them wrong by making a breakthrough discovery in the field of bee research — one that could potentially reverse a devastating pandemic in bee populations. And when people told him he didn’t “look” like a scientist, he remained true to himself and redefined what a scientist could look like. Dr. Ramsey has mastered the art of unconventional thinking to arrive at innovative solutions to some of the most significant challenges shaping the future of our society and teaches organizations and individuals how they can do the same as they address their most-pressing challenges in business and life head-on.

Described as “your friendly neighborhood entomologist,” Dr. Ramsey is the endowed professor of entomology at the University of Colorado Boulder, where he teaches about effective communication and how understanding of the deep interconnectedness of all organisms can solve real-world problems. He is also the founder of The Ramsey Research Foundation, which conducts cutting-edge, novel research on issues affecting pollinator health globally — including parasite spread, disease management and habitat preservation. He has used his exceptional skillset working in academia, industry, and government, including alongside the U.S. Supreme Court, House of Representatives and the United States Department of Agriculture.

A powerful voice in the science community and beyond, Dr. Ramsey is a National Geographic explorer who was recognized by the publication as a 2022 Wayfinder Award recipient, which honors individuals leading a new age of exploration through science, education, conservation, technology, and storytelling. He has shared his insights and expertise in the Hulu docuseries Your Attention Please, as well as in The Washington Post, on NPR, CNN, Wired, CBS Mornings, Khan Academy, Seeker, The Today Show, among other outlets. He also authored a chapter in the book The Future of Exploration, in which 35+ world-renowned science leaders share firsthand accounts of adventure and discovery in their fields. Additionally, Dr. Ramsey leverages social media and his YouTube channel (“Doctor Buggs”) to inspire the next generation of curious minds and introduce them to all the possibilities that exist for them to flourish within STEM. A passionate advocate for diversity, equity and inclusion at the highest levels, he is determined to create a future where everyone has equal opportunities for success, regardless of their background or appearance.

Dr. Ramsey graduated with a Bachelor of Science in Entomology from Cornell and later earned a PhD at the University of Maryland. He completed his post-doctoral training at USDA-ARS Bee Research Laboratory.
Jaidalyn Rand

Director, Industry Relations

Healthcare Distribution Alliance
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Jaidalyn Rand

Director, Industry Relations

Healthcare Distribution Alliance
- C1: Benchmarking Progress Throughout the DSCSA Stabilization Period
  Monday, March 11, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Lisa Schwartz

Senior Director, Professional Affairs

National Community Pharmacists Association
- E1: Dispenser Perspectives on the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 7
Lisa Schwartz

Senior Director, Professional Affairs

National Community Pharmacists Association
- E1: Dispenser Perspectives on the DSCSA Stabilization Period
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 7
Lisa is knowledgeable on pharmacy practice issues including pharmacy operations, pharmacy quality measurement, DSCSA, pharmacy automation, and health IT. She utilizes her unique skills to support pharmacy owners nationwide on a variety of practice transformation and business issues.
Kala Shankle

Vice President, Regulatory Affairs

Healthcare Distribution Alliance
- E1: Dispenser Perspectives on the DSCSA Stabilization Period
- G1: FDA’s Final DSCSA Guidance: HDA Review and Compliance Considerations
Kala Shankle

Vice President, Regulatory Affairs

Healthcare Distribution Alliance
- E1: Dispenser Perspectives on the DSCSA Stabilization Period
- G1: FDA’s Final DSCSA Guidance: HDA Review and Compliance Considerations
Kala Shankle is Vice President of Regulatory Affairs. In this role, Shankle leads HDA’s regulatory activities and engagement for members’ priority issues.

Prior to joining HDA, Shankle was an attorney at Epstein, Becker and Green, where she counseled pharmaceutical supply chain stakeholders on regulatory and compliance matters. Previously, Shankle provided legal counsel, developed policy solutions and led regulatory engagement for the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA) and a state pharmacy association in Florida.

She received both her Juris Doctor and Bachelor of Science from Florida State University. She is an active member and prior Board member for the American Society for Pharmacy Law.
Maria Shea

Wellness Expert, Psychotherapist, Mindset Coach

Awaken Counseling
- E4: Stress Reduction for Peace, Productivity and Wellness
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 9
Maria Shea

Wellness Expert, Psychotherapist, Mindset Coach

Awaken Counseling
- E4: Stress Reduction for Peace, Productivity and Wellness
  Tuesday, March 12, 2024 | 10:00—11:00 AM
  
  - Sinatra Ballroom Salons 9
Maria Shea is a professional counselor, speaker, and coach. She promotes well-being by combining modern psychology with ancient wisdom and mindset coaching. Her approach inspires positive transformation with individuals and groups in their personal and professional development.
Alex Soukhanov

Partner/Owner

True North Group LLC
- F4: Cyber Resiliency to Keep Freight Moving: Case Studies in Marine Transportation Cybersecurity and the Journey to Resilience
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 9
Alex Soukhanov

Partner/Owner

True North Group LLC
- F4: Cyber Resiliency to Keep Freight Moving: Case Studies in Marine Transportation Cybersecurity and the Journey to Resilience
  Tuesday, March 12, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salons 9
Alex has dedicated the past eleven years of work to cybersecurity for marine transportation and port facilities, which began as operational research on the potential safety impacts of cyber to vessel navigation and cargo operations, then later culminated in the co-founding and establishment of True North Group LLC. True North provides managed cybersecurity services for marine transportation and logistics, with the mission of helping clients defend against cyber threats to keep business and cargo moving. He is a master mariner and a commissioned state maritime pilot in Massachusetts with thirty years of experience in the industry, thirteen of which were at sea in maritime trade, military sealift, and specialty maritime operations.

Alex serves as Chair and co-founder of the Maritime Exchange for Digital Security (MEDS), and previously served the industry as Co-Chair of the US Department of State’s Overseas Security Advisory Council (OSAC) Maritime Security Working Group (MSWG). He is a member of the HDA Pharmaceutical Cargo Security Coalition (PCSC), Transported Asset Protection Association (TAPA Americas), the Maritime Association of the Port of New York and New Jersey, the National Association of Waterfront Employers (NAWE), the Boston Marine Society, and the Marine Society of New York. He earned a B.S. in Marine Transportation from the Massachusetts Maritime Academy, and an M.A in Defense and Strategic Studies from the US Naval War College, with a concentration in Information Operations and Cybersecurity.
Stephen Stalker

VP, Drug Shortages

McKesson - U.S. Pharma
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Stephen Stalker

VP, Drug Shortages

McKesson - U.S. Pharma
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Stephen Stalker is vice president of Drug Shortages at McKesson. He is responsible for advancing, coordinating, and communicating McKesson’s efforts to mitigate drug shortages.

Stephen has more than 20 years of experience in the pharmaceutical industry. He first joined McKesson in 2009 and has spent the past 14 years serving in roles of increasing responsibility across operations, analytics, finance, and category management within the McKesson Medical Surgical alternate site and U.S. Pharmaceutical core distribution businesses. Most recently, he led Generics Sourcing for ClarusONE Sourcing Services, a McKesson-Walmart joint venture providing responsible, best-in-class generic pharmaceutical sourcing services that lower costs for its members and their customers.

Skilled at understanding and balancing stakeholder perspectives in dynamic markets, Stephen recently embraced the newly created role in drug shortages to assist in addressing a challenge shared across the healthcare industry.

Stephen holds a Bachelor of Arts degree and Master of Business Administration from the University of Virginia and resides with his family in Richmond, Virginia.
Tim Stearns

Senior Director, Industry Relations

Healthcare Distribution Alliance
Tim Stearns

Senior Director, Industry Relations

Healthcare Distribution Alliance
Tim Stearns is a Senior E-Commerce Analyst with Baxter HealthCare, focusing primarily on the distributor customer base. With over 22 years of experience in information systems, he has integrated back–end systems and implemented numerous EDI transaction sets focused on contract/chargeback administration, customer credit and invoicing, returns processing, order management and shipping notices, track–and–trace /pedigree systems design, customer–to–HIN alignment with HIBCC and distributor Fee for Service/inventory management agreements. Tim has served twice as co–chair of the HDMA Business Technology Committee, member of the HDMA eCommerce Task Force, member of the CSOS Working Group and the Health Industry Business Communications Council E-Business Council.
Stephanie Trunk

Partner

ArentFox Schiff LLP
- D2: Overview of the Rapidly Shifting Reimbursement Policy Landscape
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Sinatra Ballroom Salon 6
Stephanie Trunk

Partner

ArentFox Schiff LLP
- D2: Overview of the Rapidly Shifting Reimbursement Policy Landscape
  Monday, March 11, 2024 | 3:15—4:15 PM
  
  - Sinatra Ballroom Salon 6
Stephanie Trunk is a partner in the Health Law Group at Arent Fox LLP in Washington, D.C. Ms. Trunk counsels pharmaceutical and device manufacturers, distributors and their customers on regulatory, reimbursement and compliance matters. Her practice extends to counseling on drug pricing and government price reporting, HIPAA and privacy matters, counseling on Medicare Part D, developing corporate compliance programs, representing clients in contract negotiations and providing transactional support to her clients.

Prior to joining Arent Fox LLP, Ms. Trunk was in-house counsel to a pharmacy benefit management company. Ms. Trunk is the author of numerous chapters in health law treatises including a chapter on Controlling Fraud, Waste and Abuse in the Medicare Part D Program in the ABA/BNA's Health Care Fraud and Abuse: Practical Perspectives.

She received a JD with Highest Honors from the George Washington University Law School in 2003. Ms. Trunk also has a graduate certificate in health management from the George Washington University School of Public Health (2003) and she received a BS in Accounting Summa Cum Laude from the University of Maryland in 1997.
Brian P. Waldman

Partner

ArentFox Schiff LLP
- G1: FDA’s Final DSCSA Guidance: HDA Review and Compliance Considerations
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Brian P. Waldman

Partner

ArentFox Schiff LLP
- G1: FDA’s Final DSCSA Guidance: HDA Review and Compliance Considerations
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salons 7
Brian Waldman concentrates his practice in the area of food and drug law and advertising law, counseling clients primarily on pharmaceutical, medical device, food, dietary supplement and cosmetic issues, with particular emphasis on developing effective strategies for introducing and distributing new products. Brian advises clients on a broad range of legal and regulatory issues in all phases of a product’s life cycle, including (i) developing appropriate strategies for the introduction of new ingredients and finished products, (ii) coordinating pre-market safety, efficacy, and claims evaluations, (iii) preparing FDA-related applications and notifications, (iv) designing compliant and effective labeling, advertising, and promotional materials, as well as educational materials, (v) ensuring post-marketing regulatory compliance, including compliance with adverse event reporting requirements and limitations on off-label promotion, and (vi) responding to threatened enforcement action. Brian has been advising clients including HDA on drug distribution issues since 1995.
Kirsten Wing Foster

Director, Federal Government Affairs

Healthcare Distribution Alliance
- B2: State of the Union: 2024 Federal Policy Outlook
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salon 6
Kirsten Wing Foster

Director, Federal Government Affairs

Healthcare Distribution Alliance
- B2: State of the Union: 2024 Federal Policy Outlook
  Monday, March 11, 2024 | 11:15—12:15 PM
  
  - Sinatra Ballroom Salon 6
Heather Zenk

President, US Supply Chain

Cencora, Inc.
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Heather Zenk

President, US Supply Chain

Cencora, Inc.
- G2: Addressing Drug Shortages
  Tuesday, March 12, 2024 | 2:00—3:00 PM
  
  - Sinatra Ballroom Salon 6
Heather Zenk, R.Ph., PharmD., is President of the US Supply Chain, Cencora. In this role, she has responsibly for the entire distribution network of human and animal health products, as well as developing and implementing traceability business processes and technology that will enhance patient safety, further secure the pharmaceutical supply chain, and create broader service offerings to manufacturer partners and Cencora customers. In addition, Heather also manages customer support, business enablement efforts, in addition to replenishment and manufacturer operations covering manufacturer programs and data.

Heather’s combination of operational skills and business acumen uniquely positioned her to lead Cencora’s COVID-19 response team. In this capacity, she served as a vital resource to our associates, hospital systems and dispenser customers, as well as our manufacturer partners helping them navigate the complexities that COVID-19 brought to the pharmaceutical supply chain.

Heather has 20 years of pharmacy, procurement, distribution, and supply chain experience, which she has utilized in her career at Cencora including that of SVP, Replenishment and Manufacturer Operations, Vice President, Distribution Center Manager at the Chicago Distribution Center, SAP business liaison; and running operations at the Canadian Distribution network.

Heather received a Bachelor of Arts degree from the College of St. Benedict, St. Joseph, MN, and a Doctorate of Pharmacy degree from the University of Minnesota.

Registration and Hotel Information

Genesis Argueta
Sponsorship Opportunities

Lisa Kanfer
Exhibit Opportunities

Michelle Leslie
Membership

Lisa Gallagher
Conference Schedule, Speaker Information, and Education Content

Subrina Ghorashi

We use cookies, pixels and other technology to understand our users better and ensure that we give you the best experience on our website.

2024 Distribution Management Conference and Expo

March 10-13, 2024 | JW Marriott Desert Springs Resort & Spa

2024 Distribution Management Conference and Expo

March 10-13, 2024 | JW Marriott Desert Springs Resort & Spa

Speakers

Stacey Allaster

Stacey Allaster

Chris J. Anderson

Chris J. Anderson

Scott Biggs

Scott Biggs

Josh M. Bolin

Josh M. Bolin

Andrew Boyle

Andrew Boyle

Randy V. Bradley

Randy V. Bradley

Scott Brown

Scott Brown

Jason Chou

Jason Chou

Ely Colón

Ely Colón

Kevin Cross

Kevin Cross

Deedre Daniel

Deedre Daniel

Chester "Chip" Davis, Jr.

Chester "Chip" Davis, Jr.

Ashley Y. DeFlice

Ashley Y. DeFlice

Tim Donelon

Tim Donelon

Heather Easterling

Heather Easterling

Charles H. Forsaith

Charles H. Forsaith

Kristen L. Freitas

Kristen L. Freitas

Perry L. Fri

Perry L. Fri

Michael Ganio

Michael Ganio

John A. Gilbert

John A. Gilbert

Rena K. Goins

Rena K. Goins

Stacey Gordon

Stacey Gordon

Gregg A. Gorniak

Gregg A. Gorniak

Kim Grinston

Kim Grinston

Mark J. Hardy

Mark J. Hardy

Scott T. Hatakeyama

Scott T. Hatakeyama

Carla Howard

Carla Howard

Courtney Johnson

Courtney Johnson

Michelle L. Keller

Michelle L. Keller

Melissa Kellstrom

Melissa Kellstrom

Mark Klawitter

Mark Klawitter

Blair Korman

Blair Korman

Abha Kundi

Abha Kundi

Leah D. Lindahl

Leah D. Lindahl

Nicolette Louissaint

Nicolette Louissaint

David G. Mason

David G. Mason

Michael J. Mazur

Michael J. Mazur